Journal
CELL DEATH & DISEASE
Volume 6, Issue -, Pages -Publisher
SPRINGERNATURE
DOI: 10.1038/cddis.2015.289
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [NSFC 81202014, NSFC 81130041]
- Fundamental Research Funds for the Central Universities
- China Scholarship Council [CSC 2009628126]
- Terry Fox Foundation of the National Cancer Institute of Canada
- NIH Pacific Northwest Prostate Specialized Programs of Research Excellence
- 973 Program of China [2012CB518300]
- United States Army [W81XWH-11-1-0491]
Ask authors/readers for more resources
Loss of DAB2IP, a novel tumor suppressor gene, is associated with the high risk of aggressive prostate cancer (PCa). Previously, we reported that DAB2IP modulated androgen receptor activation in the development of castration-resistant PCa; however, its direct action on the failure of androgen deprivation therapy (ADT) remains largely unknown. In this study, we showed that DAB2IP knockdown could significantly enhance in vitro growth and colony formation of PCa cells following ADT as well as tumorigenicity in pre-castrated nude mice. In addition, DAB2IP loss stabilized mitochondrial transmembrane potential, prevented release of cytochrome c, Omi/HtrA2 and Smac from the mitochondria to the cytoplasm and inhibited intrinsic apoptosis induced by ADT. Mechanistically, DAB2IP could interact with the signal transducer and activator of transcription 3 (STAT3) via its unique PR domain and suppress STAT3 phosphorylation and transactivation, leading to the inhibition of survivin expression in PCa cells. Moreover, the luminal epithelia in DAB2IP(-/-) mice with more activated STAT3 and survivin expression were resistant to castration-induced apoptosis. Consistently, DAB2IP expression inversely correlated with STAT3 phosphorylation and survivin expression in PCa patients. Together, our data indicate that DAB2IP loss reprograms intracellular signal transduction and anti-apoptotic gene expression, which potentiates PCa cell survival from ADT-induced cell death.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available